Memarzadeh, Sanaz

A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas

Soragni, A., Janzen, D. M., Johnson, L. M., Lindgren, A. G., Thai-Quynh Nguyen, A., Tiourin, E., Soriaga, A. B., Lu, J., Jiang, L., Faull, K. F., et al. (2016) · Cancer Cell

Cancer-related Molecular PathwaysOvarian cancer diagnosis and treatment

Cited by 341

A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids

Phan, N., Hong, J. J., Tofig, B., Mapua, M., Elashoff, D., Moatamed, N. A., Huang, J., Memarzadeh, S., Damoiseaux, R., & Soragni, A. (2019) · Communications Biology

Cancer Cells and Metastasis3D Printing in Biomedical Research

Cited by 269

Enhanced Paracrine FGF10 Expression Promotes Formation of Multifocal Prostate Adenocarcinoma and an Increase in Epithelial Androgen Receptor

Memarzadeh, S., Xin, L., Mulholland, D. J., Mansukhani, A., Wu, H., Teitell, M. A., & Witte, O. N. (2007) · Cancer Cell

Prostate Cancer Treatment and ResearchFibroblast Growth Factor Research

Cited by 201

Expression of stromal progesterone receptor and differential methylation patterns in the endometrium may correlate with response to progesterone therapy in endometrial complex atypical hyperplasia

Neal, A. S., Nunez, M., Lai, T., Tosevska, A., Morselli, M., Amneus, M., Zakhour, M., Moatamed, N. A., Pellegrini, M., & Memarzadeh, S. (2020) · Reproductive Sciences

Endometrial and Cervical Cancer TreatmentsEpigenetics and DNA Methylation

Cited by 11